Skip to content

Obstetrics

Thrombocytopenia Management

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (opens new window)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Source‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Indexed‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (opens new window)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (opens new window)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Source‎: Blood 2020;136(26):3056-61.

Indexed‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (opens new window)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (opens new window)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Source‎: Asian J Transfus Sci 2016;10(2):155-8.

Indexed‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (opens new window)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (opens new window)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Source‎: Blood 2013;121(3):537-45.

Indexed‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (opens new window)